Laryngeal leishmaniasis in a patient taking inhaled corticosteroids
- 1Department of Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK
- 2Department of Respiratory Medicine, Warwick Hospital, Warwick, UK
- 3Warwick Hospital, Warwick, UK
- Correspondence to Dr Rachel Margaret Roberts, rachel.cary{at}gmail.com
- Accepted 7 June 2016
- Published 21 June 2016
Summary
We present a case of a man in his late 60s, who had spent 3–4 months of the year in rural Spain, presenting with intermittent hoarseness of voice. He had a background of asthma and bronchiectasis, and was taking inhaled corticosteroids. His dysphonia was initially managed as bronchiectasis with little improvement. Bronchoscopy revealed a cystic lesion on his left vocal fold, and tissue biopsy revealed Leishmania amastigotes. This confirmed a diagnosis of laryngeal leishmaniasis. We propose that this is likely secondary to his inhaled corticosteroid therapy. The infection was treated with a 30-day course of miltefosine, and at most recent follow-up the patient was deemed free from leishmanial infection.








